Csomor Péter, Liktor Balázs, Liktor Bálint, Szekanecz Zoltán, Sziklai István, Karosi Tamás
Department of Otolaryngology and Head and Neck Surgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
Acta Otolaryngol. 2012 Jun;132(6):624-31. doi: 10.3109/00016489.2011.653669. Epub 2012 Mar 4.
This study is the first to establish that bone morphogenetic protein 5 (BMP5) plays a role in the pathogenesis of otosclerosis. These results confirm that elevated expression levels of BMPs, members of the transforming growth factor (TGF)-β superfamily, contribute to the pathologically increased bone turnover in early, active stages of otosclerosis.
Otosclerosis is a complex bone remodeling disorder of the otic capsule, which might be characterized by increased expression of different types of BMPs. TGF-β and BMP are both members of the TGF-β superfamily and play a critical role in bone resorption and new bone formation. It has been suggested that BMP and its receptors may be involved in the pathologically increased bone turnover observed in otosclerosis.
Fifty-one otosclerotic and 16 non-otosclerotic ankylotic stapes footplates were histologically analyzed: conventional hematoxylin-eosin staining and BMP2, 4, 5, and 7specific immunofluorescent assays were performed. Cortical bone fragments (n = 35) and incus specimens (n = 6) were used as negative controls.
Active otosclerosis (n = 39) was characterized by increased expression of BMP2, 4, 5, and 7. Inactive cases of otosclerosis (n = 12) were characterized by negative immunoreaction for BMPs. Non-otosclerotic stapes specimens (n = 16) and negative controls (n = 41) showed negligible BMP expression. The BMP expression pattern showed a strong correlation with the histological activity of otosclerosis.
本研究首次证实骨形态发生蛋白5(BMP5)在耳硬化症的发病机制中起作用。这些结果证实,转化生长因子(TGF)-β超家族成员骨形态发生蛋白(BMPs)表达水平升高,导致耳硬化症早期活跃阶段病理性骨转换增加。
耳硬化症是一种复杂的耳囊骨重塑疾病,其特征可能是不同类型BMPs表达增加。TGF-β和BMP都是TGF-β超家族成员,在骨吸收和新骨形成中起关键作用。有人提出,BMP及其受体可能参与耳硬化症中观察到的病理性骨转换增加。
对51个耳硬化和16个非耳硬化性镫骨底板进行组织学分析:进行常规苏木精-伊红染色以及BMP2、4、5和7特异性免疫荧光检测。皮质骨碎片(n = 35)和砧骨标本(n = 6)用作阴性对照。
活动性耳硬化症(n = 39)的特征是BMP2、4、5和7表达增加。非活动性耳硬化症病例(n = 12)的特征是对BMPs免疫反应阴性。非耳硬化性镫骨标本(n = 16)和阴性对照(n = 41)显示BMP表达可忽略不计。BMP表达模式与耳硬化症的组织学活性密切相关。